Dario Eklund

Vorstandsvorsitzender bei SANTHERA PHARMACEUTICALS HOLDING AG

Vermögen: 2 Mio $ am 31.05.2026

58 Jahre

Health Technology

Consumer Services

Profil

Dario Eklund is currently the Chief Executive Officer at Santhera Pharmaceuticals Holding AG since 2019.
Formerly, the roles included Commercial Director at Novartis AG from 1994 to 2002, General Manager-Switzerland at Sanofi from 2002 to 2004, VP-Business Development & Gintuit Business Unit at Organogenesis, Inc. from 2004 to 2014, Head-Global Business Operations at Vifor Pharma Management AG from 2014 to 2019, Chief Commercial Officer at Corden Pharma Fribourg SA from 2017 to 2019, Member-Supervisory Board at Vifor Fresenius Medical Care Renal Pharma Ltd. from 2017 to 2019, and General Manager-Switzerland Region at Aventis Pharma AG.
Education includes graduate studies at Hanken Svenska Handelshögskolan.

Bekannte Unternehmensbeteiligungen

Unternehmen	Datum	Anzahl der Aktien	Bewertung	Datum der Bewertung
SANTHERA PHARMACEUTICALS HOLDING AG 0,74 %	31.12.2024	110 526 ( 0,74 % )	2 Mio $	31.05.2026

Aktive Positionen von Dario Eklund

Unternehmen	Position	Beginn
SANTHERA PHARMACEUTICALS HOLDING AG	Vorstandsvorsitzender	01.12.2019

Alle aktiven Positionen von Dario Eklund

Ehemalige bekannte Positionen von Dario Eklund

Unternehmen	Position	Ende
Vifor Pharma Management AG Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency	Corporate Officer/Principal	30.09.2019
VIFOR PHARMA	Corporate Officer/Principal	30.09.2019
Vifor Fresenius Medical Care Renal Pharma Ltd. Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease	Direktor/Vorstandsmitglied	01.01.2019
Organogenesis, Inc. Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products	Corporate Officer/Principal	01.01.2014
SANOFI	Corporate Officer/Principal	01.01.2004

Sehen Sie sich die Erfahrung von Dario Eklund im Detail an

Ausbildung von Dario Eklund

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Dario Eklund im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	9
Organogenesis, Inc. Organogenesis, Inc. Medical SpecialtiesHealth Technology Designs and manufactures regenerative medical products	Health Technology
Sanofi Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines	Health Technology
Novartis AG Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products	Health Technology
Vifor Pharma AG Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services	Health Technology
Santhera Pharmaceuticals Holding AG Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases	Health Technology
Aventis Pharma AG
Vifor Pharma Management AG Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency	Health Technology
Hanken Svenska Handelshögskolan Hanken Svenska Handelshögskolan Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Vifor Fresenius Medical Care Renal Pharma Ltd. Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies for patients with chronic kidney disease	Health Technology